Biotech Losers: Aegerion Pharmaceuticals (NASDAQ:AEGR), Insys Therapeutics (NASDAQ:INSY), NPS Pharmaceuticals (NASDAQ:NPSP), XOMA Corp (NASDAQ:XOMA)

The Rosen Law Firm, P.A. reminds purchasers of Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) between March 15, 2012 and January 9, 2014, inclusive (the “Class Period”) of the important Mach 17, 2014 lead plaintiff deadline in the class action seeking remedies under the federal securities laws. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) stock performance was -5.40% in last session and finished the day at $53.74. Traded volume was 1,222,609 … Continue reading Biotech Losers: Aegerion Pharmaceuticals (NASDAQ:AEGR), Insys Therapeutics (NASDAQ:INSY), NPS Pharmaceuticals (NASDAQ:NPSP), XOMA Corp (NASDAQ:XOMA)

Biotech Gainers: Insys Therapeutics Inc (NASDAQ:INSY), Oxygen Biotherapeutics (NASDAQ:OXBT), Halozyme Therapeutics (NASDAQ:HALO), Cytori Therapeutics (NASDAQ:CYTX)

Insys Therapeutics (NASDAQ:INSY) hit a new 52-week high during trading on Tuesday following a better than expected earnings announcement, AnalystRatings.NET reports. Insys Therapeutics Inc (NASDAQ:INSY) stock performance was 21.73% in last session and finished the day at $83.37. Traded volume was 1,203,992 million shares in the last session and the average volume of the stock remained 263.48 million shares. The beta of the stock remained … Continue reading Biotech Gainers: Insys Therapeutics Inc (NASDAQ:INSY), Oxygen Biotherapeutics (NASDAQ:OXBT), Halozyme Therapeutics (NASDAQ:HALO), Cytori Therapeutics (NASDAQ:CYTX)

FB Nasdaq FB Facebook

Biotech Stocks Touching New Highs: Clovis Oncology (NASDAQ:CLVS), Vanda Pharmaceuticals (NASDAQ:VNDA), Insys Therapeutics (NASDAQ:INSY), Albany Molecular Research (NASDAQ:AMRI)

Clovis Oncology Inc. reported a fourth quarter loss of $0.92 per share after the bell Thursday, compared to the loss of $0.81 per share last year. Clovis Oncology Inc. (NASDAQ:CLVS) stock performance was 1.58% in last session and finished the day at $79.62. Traded volume was 0.00 shares in the last session and the average volume of the stock remained 589,825.00 shares. The beta of … Continue reading Biotech Stocks Touching New Highs: Clovis Oncology (NASDAQ:CLVS), Vanda Pharmaceuticals (NASDAQ:VNDA), Insys Therapeutics (NASDAQ:INSY), Albany Molecular Research (NASDAQ:AMRI)

Top News : Carnival Corporation (NYSE:CCL), Morgan Stanley (NYSE:MS), TransAlta Corp. (NYSE:TAC), Agilent Technologies Inc. (NYSE:A), T-Mobile US, Inc. (NYSE:TMUS)

Carnival Corporation (NYSE:CCL) announced it has signed a memorandum of understanding (MOU) with the China State Shipbuilding Corporation (CSSC) to explore the possibility of a joint venture aimed at accelerating the development and growth of the Chinese cruise industry, expected to be one of the largest cruise markets in the world with 4.5 million passengers by 2020, according to the Chinese Ministry of Transport (MOT). … Continue reading Top News : Carnival Corporation (NYSE:CCL), Morgan Stanley (NYSE:MS), TransAlta Corp. (NYSE:TAC), Agilent Technologies Inc. (NYSE:A), T-Mobile US, Inc. (NYSE:TMUS)

Active Watch List: INSYS Therapeutics (NASDAQ:INSY), Celladon Corporation (NASDAQ:CLDN), WisdomTree Investments, Inc. (NASDAQ:WETF), Arotech Corporation (NASDAQ:ARTX), DigitalGlobe, Inc. (NYSE:DGI)

Insys Therapeutics, Inc. (NASDAQ:INSY) announced that the FDA has granted orphan drug status to its pharmaceutical cannabidiol (CBD), for the treatment of glioblastoma multiforme (GBM.V). Glioblastoma multiforme is the most common and aggressive form of malignant primary brain tumor. INSYS Therapeutics, Inc. (NASDAQ:INSY) belongs to Healthcare sector. Its net profit margin is 31.70% and weekly performance is -4.03%. On last trading day company shares ended … Continue reading Active Watch List: INSYS Therapeutics (NASDAQ:INSY), Celladon Corporation (NASDAQ:CLDN), WisdomTree Investments, Inc. (NASDAQ:WETF), Arotech Corporation (NASDAQ:ARTX), DigitalGlobe, Inc. (NYSE:DGI)

Investors Are Watching : Linear Technology (NASDAQ:LLTC), Technical Communications (NASDAQ:TCCO), Vaalco Energy (NYSE:EGY), INSYS Therapeutics (NASDAQ:INSY), Marrone Bio (NASDAQ:MBII)

On 17 JULY Linear Technology Corporation (NASDAQ:LLTC) said that it is again eyeing Camas for a major expansion, and a decision could come later this summer. Linear Technology Corporation (NASDAQ:LLTC) belongs to Technology sector. Its net profit margin is 33.10% and weekly performance is -2.38%. On last trading day company shares ended up $44.25. Linear Technology Corporation (NASDAQ:LLTC) distance from 50-day simple moving average (SMA50) … Continue reading Investors Are Watching : Linear Technology (NASDAQ:LLTC), Technical Communications (NASDAQ:TCCO), Vaalco Energy (NYSE:EGY), INSYS Therapeutics (NASDAQ:INSY), Marrone Bio (NASDAQ:MBII)